Drug Type Small molecule drug |
Synonyms ZK 119010, ZK-119010 |
Target |
Action antagonists, inhibitors |
Mechanism ERs antagonists(Estrogen receptors antagonists), RNA polymerase inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H32N2O2 |
InChIKeySACIXOLGIWUXTG-UHFFFAOYSA-N |
CAS Registry127451-69-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | Germany | 01 Jan 1994 | |
Carcinoma | Discovery | Germany | - |